Northeast Investment Management
Source: SEC Form 13F · as of Mar 2026Northeast Investment Management holds 11 biotech & pharma companies tracked by BioSniper, totaling $117.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$117.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 54,032 | $49.7M |
| JNJJOHNSON & JOHNSON | 170,284 | $41.6M |
| ABTABBOTT LABORATORIES | 85,260 | $8.8M |
| MRKMerck & Co., Inc. | 48,692 | $5.9M |
| NVSNovartis AG | 28,892 | $4.4M |
| ABBVAbbVie Inc. | 12,020 | $2.6M |
| AMGNAMGEN INC | 4,783 | $1.7M |
| PFEPFIZER INC | 38,032 | $1.1M |
| PMPhilip Morris International Inc | 6,392 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 6,407 | $389K |
| IDXXIDEXX LABORATORIES INC /DE | 515 | $289K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.